Novartis faces 15-day suspension by Japanese health ministry
The Japanese health ministry has warned Novartis it plans to suspend its business in Japan, a move the company says will bring “manageable” costs.
Archives for February 3, 2015
CMO free? Novo Nordisk investing $760m in homegrown network
Novo Nordisk will invest up to $760m in its manufacturing network in the coming year to support the growth of its insulin portfolio.
CROs call for better ways to leverage investigative site relationships
Improving investigative site relationships in 2015 is a top priority for pharma and CRO (contract research organization) execs, according to a roundtable recently hosted by the Tufts Center for the Study of Drug Development.
Analyst: Pfizer's withdrawal from Repligen deal "not smart" amid growing Big Pharma interest in SMA
Pfizer must act fast to convince investors it can compete with Roche and Biogen Idec for a share of the spinal muscular atrophy (SMA) market says analyst.
US FDA seeks modest budget bump for FY2016
The US Food and Drug Administration (FDA) is requesting a budget of $4.9bn for fiscal year (FY) 2016 – a 9% increase over the enacted budget for FY 2015.
ScinoPharm: profits fall on higher costs, an idle plant and lower Qsymia sales
ScinoPharm was hurt by weak US demand for the weight loss pill Qsymia, higher raw material prices and costs associated with its still unapproved plant in China in 2014.
Icon pushes further into scientific comms, market access with $120m buy
Public CRO Icon ($ICLR) has agreed to acquire scientific communications and market access firm MediMedia Pharma Solutions for $120m (€106m) in cash.